Search Menu

Intl Drug Resistance Workshop 14 Quebec 2005

14th International HIV Drug Resistance Workshop (14th IHDRW), 7-11 June 2005, Quebec City, Canada

Genetic factors affecting HIV infection and progression rates: immunological factors relating to entry inhibitors

Resistance during MTCT strategies: new data on protective benefit of Combivir added to single-dose nevirapine, and impact of treatment and breastfeeding on the infant

Reduced replicative capacity of M184V explains benefit of 3TC monotherapy compared to stopping all drugs

Interaction between tenofovir and ddI in triple-nucleoside combinations: role of M184V in explaining resistance on failure

Predicting clinical responses to ddI from genotypic resistance

Under-detection of transmission of transmitted resistance and impact on treatment response

Risk of death in UK after diagnosis of 3-class resistance